Anti-cell surface antigen monoclonal antibody MT107

Drug Profile

Anti-cell surface antigen monoclonal antibody MT107

Alternative Names: MT 107

Latest Information Update: 07 Dec 2005

Price : $50

At a glance

  • Originator Micromet
  • Class Bispecific antibodies; Monoclonal antibodies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation; Rheumatoid arthritis

Most Recent Events

  • 07 Dec 2005 Discontinued - Preclinical for Inflammation in Germany (unspecified route)
  • 07 Dec 2005 Discontinued - Preclinical for Rheumatoid arthritis in Germany (unspecified route)
  • 06 Mar 2002 Preclinical trials in Inflammation in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top